AHI Advanced Health Intelligence Ltd

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2023

 

Commission File Number: 001-41089

 

Advanced Health Intelligence Ltd

(Translation of registrant’s name into English)

 

71-73 South Perth Esplanade, Unit 5

South Perth, WA 6151

Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Attached as Exhibit 99.1 to this Report on Form 6-K is a copy of the press release of Advanced Health Intelligence Ltd, dated August 24, 2023: “Company Presentation - Smartphone Biometric Health Assessment”.

 

99.1

Press release dated August 24, 2023

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	ADVANCED HEALTH INTELLIGENCE LTD
Date: August 24, 2023	By:	/s/ Scott Montgomery
		Name:	Scott Montgomery
		Title:	Chief Executive Officer

 

 

2

Exhibit 99.1

 

Market Announcement August 24, 2023

 

Advanced Health Intelligence Ltd

Company Presentation -

Smartphone Biometric Health Assessment

 

South Perth, Australia August 24, 2023 - Advanced Health Intelligence Ltd (ASX/NASDAQ: AHI) (“AHI” or the “Company”) is pleased to release its latest Company Presentation.

 

This presentation highlights the advancements made in AHI’s Smartphone Biometric Health Assessment capabilities. Designed specifically for deployment from a smartphone device, this innovative application leverages AHI’s proprietary process of capturing biometric data, providing users with comprehensive health insights.

 

AHI has tailored this presentation for its shareholders to assist in understanding the company’s technology, business case and targeted market segments. AHI wishes to ensure our shareholders remain informed about the Company’s pioneering developments and future prospects.

 

The Chairman and CEO of Advanced Health Intelligence Ltd have approved this announcement.

 

For more information, contact: 

 

Scott Montgomery  Chief Executive Officer  Advanced Health Intelligence Ltd E: admin@ahi.tech

Vlado Bosanac Founder/Head of Strategy Advanced Health Intelligence Ltd E: admin@ahi.tech

 

About Advanced Health Intelligence Ltd

 

Advanced Health Intelligence Ltd (AHI) is committed to becoming a global leader in digital health, harnessing its proprietary technology and innovative processes to redefine health screening. Leveraging the ubiquity and convenience of smartphones, AHI aims to deliver a comprehensive suite of assessment tools to healthcare providers, caregivers, insurers, and governments around the world.

 

Our mission is to improve healthcare outcomes, enhance health literacy, and support the early detection and management of various health conditions.

 

Since our inception in 2014, AHI has been at the forefront of Health-tech innovation, starting with the world’s first on-device body dimensioning capability. Our patented technology has evolved into a robust suite of solutions symbolising digitised healthcare’s future.

 

Advanced Health Intelligence Ltd

ACN 602 111 115

Postal Address: PO Box 190, South Perth WA 6951

Email: investors@ahi.tech

 

 

Market Announcement August 24, 2023

 

Our key offerings include:

 

●

Body dimension and composition assessments enable the identification of obesity-related comorbidities such as diabetes.

 

●

Blood biomarker prediction includes HbA1C, HDL, LDL, and 10-year mortality risk.

 

●

Transdermal Optical Imaging, providing vital signs and cardiovascular disease risk estimates.

 

●

On-device dermatological skin identification recognises 588 skin conditions across 133 categories, including Melanoma.

 

●

Assisting partners in delivering personalised therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy.

 

At the heart of AHI is our world-class team comprising machine learning and AI experts, computer vision specialists, and medically trained data scientists. Their collective expertise ensures AHI remains at the cutting edge of health-tech innovation, tailoring our technology to meet the evolving needs of our consumers.

 

AHI’s vision extends beyond individual health assessments. We aspire to create a transformative impact at scale, driving forward a new era in digital healthcare. Our biometrically derived triage solution, accessible via a smartphone, enables our partners to identify and manage health risks at a population scale.

 

In the pursuit of proactive health management, AHI stands ready to guide healthcare providers, caregivers, insurers, and governments in triaging individuals into the most suitable care pathways. Through technology, AHI is contributing to a more efficient, effective, and inclusive global healthcare system.

 

For more information about AHI and its research initiatives, please visit: www.ahi.tech

 

Advanced Health Intelligence Ltd

ACN 602 111 115

Postal Address: PO Box 190, South Perth WA 6951

Email: investors@ahi.tech

 

 

 

---